Amylyx Pharmaceuticals, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $0Mn |
Net Profits | $-43.42Mn |
Net Profit Margins | -Inf% |
Amylyx Pharmaceuticals, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, Amylyx Pharmaceuticals, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.
Amylyx Pharmaceuticals, Inc. Common Stock’s net profit fell -4.78% since last year same period to $-43.42Mn in the Q2 2026. On a quarterly growth basis, Amylyx Pharmaceuticals, Inc. Common Stock has generated -5.18% fall in its net profits since last 3-months.
Amylyx Pharmaceuticals, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, Amylyx Pharmaceuticals, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.38 |
EPS Estimate Current Year | -0.38 |
Amylyx Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.38 - a -5.56% fall from last quarter’s estimates.
Amylyx Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -0.38.
Key Ratios
Earning Per Share (EPS) | -0.39 |
Amylyx Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) jumped 15.22% since last year same period to -0.39 in the Q2 2026. This indicates that the Amylyx Pharmaceuticals, Inc. Common Stock has generated 15.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-06 | -0.36 | -0.39 | -8.33% |
2026-05-07 | -0.34 | -0.37 | -8.82% |
